View Future GrowthQingdao Copton Technology 過去の業績過去 基準チェック /16Qingdao Copton Technologyの収益は年間平均-17.5%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間5.6% 0.3%割合で 増加しています。 Qingdao Copton Technologyの自己資本利益率は3.6%であり、純利益率は4.8%です。主要情報-17.47%収益成長率-17.58%EPS成長率Chemicals 業界の成長12.10%収益成長率0.33%株主資本利益率3.56%ネット・マージン4.78%次回の業績アップデート29 Aug 2026最近の業績更新お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2026 Results on Aug 29, 2026Qingdao Copton Technology Company Limited announced that they will report first half, 2026 results on Aug 29, 2026お知らせ • Mar 30Qingdao Copton Technology Company Limited to Report Q1, 2026 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Dec 26Qingdao Copton Technology Company Limited to Report Fiscal Year 2025 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report fiscal year 2025 results on Apr 24, 2026お知らせ • Sep 30Qingdao Copton Technology Company Limited to Report Q3, 2025 Results on Oct 25, 2025Qingdao Copton Technology Company Limited announced that they will report Q3, 2025 results on Oct 25, 2025お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2025 Results on Aug 30, 2025Qingdao Copton Technology Company Limited announced that they will report first half, 2025 results on Aug 30, 2025お知らせ • Mar 28Qingdao Copton Technology Company Limited to Report Q1, 2025 Results on Apr 30, 2025Qingdao Copton Technology Company Limited announced that they will report Q1, 2025 results on Apr 30, 2025すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Aug 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥13.23, the stock trades at a trailing P/E ratio of 78.1x. Average trailing P/E is 40x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years.Valuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥11.95, the stock trades at a trailing P/E ratio of 70.6x. Average trailing P/E is 46x in the Chemicals industry in China. Total returns to shareholders of 6.3% over the past three years.お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2026 Results on Aug 29, 2026Qingdao Copton Technology Company Limited announced that they will report first half, 2026 results on Aug 29, 2026Declared Dividend • Jun 20Dividend of CN¥0.10 announcedShareholders will receive a dividend of CN¥0.10. Ex-date: 26th June 2026 Payment date: 26th June 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (59% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has decreased over the past 96 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 34% to shift the payout ratio to a potentially unsustainable range, which is more than the 19% EPS decline seen over the last 5 years.Board Change • May 20Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 2 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Xiaofeng Gu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 24Qingdao Copton Technology Company Limited, Annual General Meeting, May 22, 2026Qingdao Copton Technology Company Limited, Annual General Meeting, May 22, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Qingdao, Shandong Chinaお知らせ • Mar 30Qingdao Copton Technology Company Limited to Report Q1, 2026 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Dec 26Qingdao Copton Technology Company Limited to Report Fiscal Year 2025 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report fiscal year 2025 results on Apr 24, 2026お知らせ • Sep 30Qingdao Copton Technology Company Limited to Report Q3, 2025 Results on Oct 25, 2025Qingdao Copton Technology Company Limited announced that they will report Q3, 2025 results on Oct 25, 2025お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2025 Results on Aug 30, 2025Qingdao Copton Technology Company Limited announced that they will report first half, 2025 results on Aug 30, 2025お知らせ • Apr 30Qingdao Copton Technology Company Limited, Annual General Meeting, May 23, 2025Qingdao Copton Technology Company Limited, Annual General Meeting, May 23, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Qingdao, Shandong Chinaお知らせ • Mar 28Qingdao Copton Technology Company Limited to Report Q1, 2025 Results on Apr 30, 2025Qingdao Copton Technology Company Limited announced that they will report Q1, 2025 results on Apr 30, 2025お知らせ • Dec 27Qingdao Copton Technology Company Limited to Report Fiscal Year 2024 Results on Apr 30, 2025Qingdao Copton Technology Company Limited announced that they will report fiscal year 2024 results on Apr 30, 2025New Risk • Nov 07New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: CN¥0.048 (vs CN¥0.046 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.048 (up from CN¥0.046 in 3Q 2023). Revenue: CN¥239.2m (down 8.5% from 3Q 2023). Net income: CN¥11.6m (up 5.0% from 3Q 2023). Profit margin: 4.8% (up from 4.2% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥8.55, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years.お知らせ • Sep 30Qingdao Copton Technology Company Limited to Report Q3, 2024 Results on Oct 31, 2024Qingdao Copton Technology Company Limited announced that they will report Q3, 2024 results on Oct 31, 2024Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: CN¥0.015 (vs CN¥0.01 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.015 (up from CN¥0.01 in 2Q 2023). Revenue: CN¥262.6m (down 2.3% from 2Q 2023). Net income: CN¥3.80m (up 42% from 2Q 2023). Profit margin: 1.4% (up from 1.0% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • Jun 28Qingdao Copton Technology Company Limited to Report First Half, 2024 Results on Aug 31, 2024Qingdao Copton Technology Company Limited announced that they will report first half, 2024 results on Aug 31, 2024お知らせ • Apr 29Qingdao Copton Technology Company Limited, Annual General Meeting, May 17, 2024Qingdao Copton Technology Company Limited, Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Qingdao, Shandong ChinaReported Earnings • Apr 28Full year 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.15 in FY 2022)Full year 2023 results: EPS: CN¥0.19 (up from CN¥0.15 in FY 2022). Revenue: CN¥1.20b (up 52% from FY 2022). Net income: CN¥47.8m (up 21% from FY 2022). Profit margin: 4.0% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Apr 19Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥9.27, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 33% over the past three years.Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥11.13, the stock trades at a trailing P/E ratio of 58.3x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 62% over the past three years.お知らせ • Mar 30Qingdao Copton Technology Company Limited to Report Q1, 2024 Results on Apr 27, 2024Qingdao Copton Technology Company Limited announced that they will report Q1, 2024 results on Apr 27, 2024Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥9.14, the stock trades at a trailing P/E ratio of 52.7x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.お知らせ • Feb 09Qingdao Copton Technology Company Limited (SHSE:603798) announces an Equity Buyback for CNY 50 million worth of its shares.Qingdao Copton Technology Company Limited (SHSE:603798) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price not more than CNY 10 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The repurchases will be made from company's own funds. The authorization will be valid for a period of 3 months.Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥8.94, the stock trades at a trailing P/E ratio of 46.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 38% over the past three years.New Risk • Jan 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.5% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).Valuation Update With 7 Day Price Move • Jan 10Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥11.90, the stock trades at a trailing P/E ratio of 62.4x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 67% over the past three years.お知らせ • Dec 29Qingdao Copton Technology Company Limited to Report Fiscal Year 2023 Results on Apr 27, 2024Qingdao Copton Technology Company Limited announced that they will report fiscal year 2023 results on Apr 27, 2024Reported Earnings • Aug 28Second quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.001 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.02 (up from CN¥0.001 in 2Q 2022). Revenue: CN¥268.8m (up 34% from 2Q 2022). Net income: CN¥2.68m (up CN¥2.54m from 2Q 2022). Profit margin: 1.0% (up from 0.1% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥11.77, the stock trades at a trailing P/E ratio of 69.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.Reported Earnings • Apr 29Full year 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.53 in FY 2021)Full year 2022 results: EPS: CN¥0.20 (down from CN¥0.53 in FY 2021). Revenue: CN¥791.6m (down 29% from FY 2021). Net income: CN¥39.6m (down 63% from FY 2021). Profit margin: 5.0% (down from 9.5% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥12.01, the stock trades at a trailing P/E ratio of 48.4x. Average trailing P/E is 27x in the Chemicals industry in China. Total loss to shareholders of 9.9% over the past three years.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 2 independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.038 (vs CN¥0.072 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.038 (down from CN¥0.072 in 3Q 2021). Revenue: CN¥169.9m (up 1.3% from 3Q 2021). Net income: CN¥7.95m (down 46% from 3Q 2021). Profit margin: 4.7% (down from 8.7% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.001 (vs CN¥0.15 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.001 (down from CN¥0.15 in 2Q 2021). Revenue: CN¥201.1m (down 37% from 2Q 2021). Net income: CN¥144.1k (down 100% from 2Q 2021). Profit margin: 0.1% (down from 9.5% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.26 in 1Q 2021). Revenue: CN¥221.4m (down 41% from 1Q 2021). Net income: CN¥30.6m (down 39% from 1Q 2021). Profit margin: 14% (in line with 1Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 2 independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.99, the stock trades at a trailing P/E ratio of 23.1x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years.Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.072 (vs CN¥0.12 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥167.7m (down 29% from 3Q 2020). Net income: CN¥14.6m (down 38% from 3Q 2020). Profit margin: 8.7% (down from 10% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.17 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥319.6m (up 16% from 2Q 2020). Net income: CN¥30.3m (down 8.4% from 2Q 2020). Profit margin: 9.5% (down from 12% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • May 02Full year 2020 earnings released: EPS CN¥0.53 (vs CN¥0.42 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥919.9m (down 5.2% from FY 2019). Net income: CN¥105.1m (up 24% from FY 2019). Profit margin: 11% (up from 8.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 12% per year.Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥11.50, the stock is trading at a trailing P/E ratio of 25.9x, up from the previous P/E ratio of 21.7x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 32%.Is New 90 Day High Low • Jan 20New 90-day high: CN¥11.50The company is up 4.0% from its price of CN¥11.07 on 23 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.Is New 90 Day High Low • Dec 28New 90-day low: CN¥9.43The company is down 11% from its price of CN¥10.60 on 30 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Dec 11New 90-day low: CN¥10.09The company is down 11% from its price of CN¥11.38 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: CN¥10.22The company is down 9.0% from its price of CN¥11.27 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥93.0m, largely unchanged from the prior year. Total revenue was CN¥954.6m over the last 12 months, up 2.1% from the prior year.収支内訳Qingdao Copton Technology の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史XSSC:603798 収益、費用、利益 ( )CNY Millions日付収益収益G+A経費研究開発費31 Mar 26903431032231 Dec 25951511012830 Sep 2597552882930 Jun 251,03762923431 Mar 251,08667933831 Dec 241,06755963230 Sep 241,142571122930 Jun 241,165571162831 Mar 241,171561172831 Dec 231,199481203230 Sep 231,101491103530 Jun 231,009461053431 Mar 23941431062931 Dec 22792401032730 Sep 22841491083130 Jun 22838561083331 Mar 22957861103731 Dec 211,1081061203930 Sep 211,0481111033630 Jun 211,1151201243431 Mar 211,0711231293431 Dec 209201051262830 Sep 20955931682930 Jun 20966831693031 Mar 20914681693031 Dec 19970851713030 Sep 19935931294730 Jun 19868861233931 Mar 19842771352431 Dec 18847761302630 Sep 18863871391530 Jun 188891021331531 Mar 188961211142231 Dec 178961201151530 Sep 17896115132030 Jun 17913130140031 Mar 17901130144031 Dec 16821113146030 Sep 16805102150030 Jun 1677095139031 Mar 1673086135031 Dec 15711831300質の高い収益: 603798は 高品質の収益 を持っています。利益率の向上: 603798の現在の純利益率 (4.8%)は、昨年(6.1%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 603798の収益は過去 5 年間で年間17.5%減少しました。成長の加速: 603798は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: 603798は過去 1 年間で収益成長率がマイナス ( -35.3% ) となったため、 Chemicals業界平均 ( 4.2% ) と比較することが困難です。株主資本利益率高いROE: 603798の 自己資本利益率 ( 3.6% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/07 13:37終値2026/08/07 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Qingdao Copton Technology Company Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2026 Results on Aug 29, 2026Qingdao Copton Technology Company Limited announced that they will report first half, 2026 results on Aug 29, 2026
お知らせ • Mar 30Qingdao Copton Technology Company Limited to Report Q1, 2026 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Dec 26Qingdao Copton Technology Company Limited to Report Fiscal Year 2025 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report fiscal year 2025 results on Apr 24, 2026
お知らせ • Sep 30Qingdao Copton Technology Company Limited to Report Q3, 2025 Results on Oct 25, 2025Qingdao Copton Technology Company Limited announced that they will report Q3, 2025 results on Oct 25, 2025
お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2025 Results on Aug 30, 2025Qingdao Copton Technology Company Limited announced that they will report first half, 2025 results on Aug 30, 2025
お知らせ • Mar 28Qingdao Copton Technology Company Limited to Report Q1, 2025 Results on Apr 30, 2025Qingdao Copton Technology Company Limited announced that they will report Q1, 2025 results on Apr 30, 2025
Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥13.23, the stock trades at a trailing P/E ratio of 78.1x. Average trailing P/E is 40x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years.
Valuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥11.95, the stock trades at a trailing P/E ratio of 70.6x. Average trailing P/E is 46x in the Chemicals industry in China. Total returns to shareholders of 6.3% over the past three years.
お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2026 Results on Aug 29, 2026Qingdao Copton Technology Company Limited announced that they will report first half, 2026 results on Aug 29, 2026
Declared Dividend • Jun 20Dividend of CN¥0.10 announcedShareholders will receive a dividend of CN¥0.10. Ex-date: 26th June 2026 Payment date: 26th June 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (59% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has decreased over the past 96 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 34% to shift the payout ratio to a potentially unsustainable range, which is more than the 19% EPS decline seen over the last 5 years.
Board Change • May 20Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 2 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Xiaofeng Gu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 24Qingdao Copton Technology Company Limited, Annual General Meeting, May 22, 2026Qingdao Copton Technology Company Limited, Annual General Meeting, May 22, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Qingdao, Shandong China
お知らせ • Mar 30Qingdao Copton Technology Company Limited to Report Q1, 2026 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Dec 26Qingdao Copton Technology Company Limited to Report Fiscal Year 2025 Results on Apr 24, 2026Qingdao Copton Technology Company Limited announced that they will report fiscal year 2025 results on Apr 24, 2026
お知らせ • Sep 30Qingdao Copton Technology Company Limited to Report Q3, 2025 Results on Oct 25, 2025Qingdao Copton Technology Company Limited announced that they will report Q3, 2025 results on Oct 25, 2025
お知らせ • Jun 30Qingdao Copton Technology Company Limited to Report First Half, 2025 Results on Aug 30, 2025Qingdao Copton Technology Company Limited announced that they will report first half, 2025 results on Aug 30, 2025
お知らせ • Apr 30Qingdao Copton Technology Company Limited, Annual General Meeting, May 23, 2025Qingdao Copton Technology Company Limited, Annual General Meeting, May 23, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Qingdao, Shandong China
お知らせ • Mar 28Qingdao Copton Technology Company Limited to Report Q1, 2025 Results on Apr 30, 2025Qingdao Copton Technology Company Limited announced that they will report Q1, 2025 results on Apr 30, 2025
お知らせ • Dec 27Qingdao Copton Technology Company Limited to Report Fiscal Year 2024 Results on Apr 30, 2025Qingdao Copton Technology Company Limited announced that they will report fiscal year 2024 results on Apr 30, 2025
New Risk • Nov 07New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: CN¥0.048 (vs CN¥0.046 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.048 (up from CN¥0.046 in 3Q 2023). Revenue: CN¥239.2m (down 8.5% from 3Q 2023). Net income: CN¥11.6m (up 5.0% from 3Q 2023). Profit margin: 4.8% (up from 4.2% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥8.55, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years.
お知らせ • Sep 30Qingdao Copton Technology Company Limited to Report Q3, 2024 Results on Oct 31, 2024Qingdao Copton Technology Company Limited announced that they will report Q3, 2024 results on Oct 31, 2024
Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: CN¥0.015 (vs CN¥0.01 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.015 (up from CN¥0.01 in 2Q 2023). Revenue: CN¥262.6m (down 2.3% from 2Q 2023). Net income: CN¥3.80m (up 42% from 2Q 2023). Profit margin: 1.4% (up from 1.0% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 28Qingdao Copton Technology Company Limited to Report First Half, 2024 Results on Aug 31, 2024Qingdao Copton Technology Company Limited announced that they will report first half, 2024 results on Aug 31, 2024
お知らせ • Apr 29Qingdao Copton Technology Company Limited, Annual General Meeting, May 17, 2024Qingdao Copton Technology Company Limited, Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Qingdao, Shandong China
Reported Earnings • Apr 28Full year 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.15 in FY 2022)Full year 2023 results: EPS: CN¥0.19 (up from CN¥0.15 in FY 2022). Revenue: CN¥1.20b (up 52% from FY 2022). Net income: CN¥47.8m (up 21% from FY 2022). Profit margin: 4.0% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Apr 19Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥9.27, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 33% over the past three years.
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥11.13, the stock trades at a trailing P/E ratio of 58.3x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 62% over the past three years.
お知らせ • Mar 30Qingdao Copton Technology Company Limited to Report Q1, 2024 Results on Apr 27, 2024Qingdao Copton Technology Company Limited announced that they will report Q1, 2024 results on Apr 27, 2024
Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥9.14, the stock trades at a trailing P/E ratio of 52.7x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.
お知らせ • Feb 09Qingdao Copton Technology Company Limited (SHSE:603798) announces an Equity Buyback for CNY 50 million worth of its shares.Qingdao Copton Technology Company Limited (SHSE:603798) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price not more than CNY 10 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The repurchases will be made from company's own funds. The authorization will be valid for a period of 3 months.
Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥8.94, the stock trades at a trailing P/E ratio of 46.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 38% over the past three years.
New Risk • Jan 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.5% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).
Valuation Update With 7 Day Price Move • Jan 10Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥11.90, the stock trades at a trailing P/E ratio of 62.4x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 67% over the past three years.
お知らせ • Dec 29Qingdao Copton Technology Company Limited to Report Fiscal Year 2023 Results on Apr 27, 2024Qingdao Copton Technology Company Limited announced that they will report fiscal year 2023 results on Apr 27, 2024
Reported Earnings • Aug 28Second quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.001 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.02 (up from CN¥0.001 in 2Q 2022). Revenue: CN¥268.8m (up 34% from 2Q 2022). Net income: CN¥2.68m (up CN¥2.54m from 2Q 2022). Profit margin: 1.0% (up from 0.1% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥11.77, the stock trades at a trailing P/E ratio of 69.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.
Reported Earnings • Apr 29Full year 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.53 in FY 2021)Full year 2022 results: EPS: CN¥0.20 (down from CN¥0.53 in FY 2021). Revenue: CN¥791.6m (down 29% from FY 2021). Net income: CN¥39.6m (down 63% from FY 2021). Profit margin: 5.0% (down from 9.5% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥12.01, the stock trades at a trailing P/E ratio of 48.4x. Average trailing P/E is 27x in the Chemicals industry in China. Total loss to shareholders of 9.9% over the past three years.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 2 independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.038 (vs CN¥0.072 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.038 (down from CN¥0.072 in 3Q 2021). Revenue: CN¥169.9m (up 1.3% from 3Q 2021). Net income: CN¥7.95m (down 46% from 3Q 2021). Profit margin: 4.7% (down from 8.7% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.
Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.001 (vs CN¥0.15 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.001 (down from CN¥0.15 in 2Q 2021). Revenue: CN¥201.1m (down 37% from 2Q 2021). Net income: CN¥144.1k (down 100% from 2Q 2021). Profit margin: 0.1% (down from 9.5% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.26 in 1Q 2021). Revenue: CN¥221.4m (down 41% from 1Q 2021). Net income: CN¥30.6m (down 39% from 1Q 2021). Profit margin: 14% (in line with 1Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 2 independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.99, the stock trades at a trailing P/E ratio of 23.1x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years.
Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.072 (vs CN¥0.12 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥167.7m (down 29% from 3Q 2020). Net income: CN¥14.6m (down 38% from 3Q 2020). Profit margin: 8.7% (down from 10% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.17 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥319.6m (up 16% from 2Q 2020). Net income: CN¥30.3m (down 8.4% from 2Q 2020). Profit margin: 9.5% (down from 12% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • May 02Full year 2020 earnings released: EPS CN¥0.53 (vs CN¥0.42 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥919.9m (down 5.2% from FY 2019). Net income: CN¥105.1m (up 24% from FY 2019). Profit margin: 11% (up from 8.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 12% per year.
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥11.50, the stock is trading at a trailing P/E ratio of 25.9x, up from the previous P/E ratio of 21.7x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 32%.
Is New 90 Day High Low • Jan 20New 90-day high: CN¥11.50The company is up 4.0% from its price of CN¥11.07 on 23 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.
Is New 90 Day High Low • Dec 28New 90-day low: CN¥9.43The company is down 11% from its price of CN¥10.60 on 30 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Dec 11New 90-day low: CN¥10.09The company is down 11% from its price of CN¥11.38 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥10.22The company is down 9.0% from its price of CN¥11.27 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥93.0m, largely unchanged from the prior year. Total revenue was CN¥954.6m over the last 12 months, up 2.1% from the prior year.